In our cohort, we found a single ATC with a deleterious CDKN2A mutation as well as four additional tumors with gene deletions, and CDKN2A therefore constitutes the most aberrantly affected cancer-related gene in the entire cohort. The gene discussed is CDKN2A; the disease is cancer.